Overview
?
Fabien Lefebvre de Ladonchamps
See more contacts
Scientific Research and Development Services
,
Drugs and Druggists' Sundries Merchant Wholesalers
,
Professional, Scientific, and Technical Services
,
Biotechnical research, commercial
,
Pharmaceuticals
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
Modelled
$24.21 million
Actual
-11.55%
$16
DEC
?
?
Berlin:22D0
Contacts
Get in Touch with 4 Principals*
-
Fabien Lefebvre de LadonchampsManaging Director and Member of the Board of Directors
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2022 (12 month period) in USD
Annual Revenue 2022
$24.21 million
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net Operating Cash | -$23 | -$50 | -$71 |
| Net Investing Cash | $0 | -$0 | -$0 |
| Net Financing Cash | -$17 | $74 | $32 |
| Net Change in Cash | -$40 | $24 | -$39 |
| Cash at Beginning of Period | $55 | $31 | $69 |
| Cash at End of Period | $15 | $55 | $31 |
| Capital Expenditure | $ | -$0 | -$0 |
| Assets (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $8 | $55 | $31 |
| Accounts Receivable | $0 | $3 | $ |
| Inventories | $ | $ | $ |
| Other Current Assets | $7 | $5 | $6 |
| Asset Summary | |||
| Total Current Assets | $16 | $63 | $37 |
| Tangible Fixed Assets | $0 | $1 | $2 |
| Intangible Assets | $ | $ | $27 |
| Total Assets | $17 | $65 | $65 |
| Liabilities (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $ | $ | $ |
| Short-Term Debt | $3 | $ | $ |
| Other Current Liabilities | $4 | $24 | $22 |
| Liability Summary | |||
| Total Current Liabilities | $7 | $24 | $22 |
| Long-Term Debt | $ | $14 | $25 |
| Other Long-Term Liabilities | $0 | $1 | $1 |
| Total Liabilities | $8 | $52 | $57 |
| Stakeholder's Equity (mil) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Equity | |||
| Common Stock | $9 | $6 | $5 |
| Retained Earnings | -$473 | -$443 | -$379 |
| Equity Summary | |||
| Total Equity | $8 | $13 | $8 |
| Shares Outstanding | 107,706,699 | 79,955,268 | 57,552,578 |